Health
Two Cases of Pancreatic Cancer Treatment with CARsgen's CT041 Published in Journal of Hematology & Oncology
SHANGHAI, Sept. 21, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced the publication of two cases of the treatment of metastatic pancreat...
2023-09-21 16:00
1434
Hepagene Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for HPG7233 THR Beta Agonist
HONG KONG and NANJING, China, Sept. 20, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical-stage biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for its HPG7233, an agonist of Thyroid H...
2023-09-20 22:00
1438
Taiwan's Premier Health Brand Unveils Best Quality Pineapple Enzyme for Digestive Health
NISORO HEALTH introduces high-quality Pineapple Enzyme, a digestive elixir blendingTaiwan's pineapples and LJ88 probiotics. It enhances digestion, promotes gut health, and is suitable for all ages. TAIPEI, Sept. 20, 2023 /PRNewswire/ -- Taiwan is renowned for its exceptional products, and NISORO...
2023-09-20 21:00
1510
Double Honors: Sanyou Bio Earns "Most Trusted Biopharmaceutical CXO Partner" and "Most Influential Partner of the Year" Awards
SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- Sanyou Bio's consecutive wins reflect our clients' trust, and our proven track record, raising expectations for our future. This recognition from peers and industry experts motivate us to remain committed to our mission, and to consistently provide high-qu...
2023-09-20 20:00
1293
Centre for Ion Beam Applications at NUS designated as IAEA's first Collaborating Centre in Singapore
The new collaboration aims to advance accelerator science technologies for
multidisciplinary real-world applications
SINGAPORE, Sept. 20, 2023 /PRNewswire/ -- The Centre for Ion Beam Applications
2023-09-20 19:31
1717
WuXi XDC Launches New Commercial Manufacturing Facilities
* New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconjugate drug substance and drug product * Doubled capacity provides greater support to the rapidly growing global bioconjugate industry WUXI, China, Sept. 20, 2023 /PRNewswire/ -- WuXi XDC, a ...
2023-09-20 18:51
1481
The First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint
SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, has announced that the multinatio...
2023-09-20 15:52
1590
MedMatch360 Partnered Up with HokuApps to Disrupt Healthcare Recruitment Paradigm through Groundbreaking Technology, Streamlining Processes and Elevating Candidate-Organization Connection
SYKESVILLE, Md., Sept. 19, 2023 /PRNewswire/ -- Together they implemented a powerful all-in-one mobility solution revolutionizing the recruitment experience by eliminating frustrations and enhancing efficiency for recruiters and healthcare providers, enabling swift identification of ideal matches...
2023-09-19 23:08
1326
Neusoft Holds the Top Market Share of Medical Imaging Information System in China
SHENYANG, China, Sept. 19, 2023 /PRNewswire/ -- Recently, IDC released the report "China's Medical Imaging Information System Market Share in 2022", in which Neusoft Corporation (Neusoft, SSE:600718) held the top market share in this sector due to its profound understanding of the market, continu...
2023-09-19 17:00
1720
Caliway Announces the Completion of Subject Recruitment in the CBL-0201EFP Phase 2-stage 2 Study Evaluating the CBL-514 in Cellulite Treatment
TAIPEI, Sept. 18, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway), a biopharmaceutical company focusing on breakthrough medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics, announced the completion of subject recruitment in the CBL-0201EFP Phase 2-stage...
2023-09-19 11:16
1214
ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility
SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ -- ST Pharm successfully marked the completion of its groundbreaking ceremony, signaling a significant step forward in expanding its oligonucleotide manufacturing capacity and capabilities. The current expansion is in response to the growing demand...
2023-09-19 09:16
1756
Lexasure Financial Group Founder & CEO Ian Lim to Receive BrandLaureate Awards for Digital Insurance Solutions and Visionary Entrepreneur of the Year
GEORGETOWN, Cayman Islands, Sept. 18, 2023 /PRNewswire/ -- Lexasure Financial
Group Limited
2023-09-18 21:00
1216
VUNO's First AI-based Prospective Study Results Published in Critical Care
SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ -- VUNO Inc., South Korean medical AI company announced that its AI-based cardiac arrest risk management system, VUNO Med®-DeepCARS™, has proven its clinical validity for the first time through a prospective study utilizing Real World Data(RWD). <...
2023-09-18 21:00
1992
Acepodia Announces Nobel Laureate Carolyn Bertozzi, Ph.D., as Chief Scientific Advisor
ALAMEDA, Calif. and TAIPEI, Sept. 18, 2023 /PRNewswire/ -- Acepodia, a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 T-cell platforms to address gaps in cancer care, today announced that N...
2023-09-18 19:00
1138
Zylox-Tonbridge was Added to the FTSE Global Equity Index Series
HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company") is pleased to learn that the Company's stock was added to the FTSE Global Equity Index Series ("GEIS"), including FTSE Global Total-Cap Index (LMSµ) and FTSE Global Micro Cap Index, according to the results o...
2023-09-18 14:51
3298
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
INCHEON, South Korea, Sept. 17, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced today a new agreement with Bristol Myers Squibb (NYSE: BMY) for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Bristol Myers Squibb and Samsung Biolog...
2023-09-18 07:57
1427
The "Jiangsu-Germany Dialogue 2023" Held in Changzhou
CHANGZHOU, China, Sept. 15, 2023 /PRNewswire/ -- On September 12, the "Jiangsu-Germany Dialogue 2023" was held inChangzhou. This marks the third year of the event being hosted inChangzhou. The conference, themed "New Energy, New Opportunities", aims to further promote cooperation betweenChina and...
2023-09-15 16:38
1931
Cure Genetics and Frametact Reach a $60 Million Collaboration and Licensing Agreement for the Development of Gene Therapy for Familial Neurological Diseases
SUZHOU, China and HONG KONG, Sept. 14, 2023 /PRNewswire/ -- Cure Genetics and Frametact Limited, a biotech company specializing in researching and developing treatments for neurological diseases, jointly announce the signing of a collaborative development and licensing agreement. The partnership ...
2023-09-14 23:00
1842
Porton Advanced and BRL Medicine Build Strategic Partnership to Accelerate Commercialization of Gene and Cell Therapies
SUZHOU, China, Sept. 14, 2023 /PRNewswire/ -- On September 13th, 2023, Porton Advanced Solutions (Porton Advanced) announced a strategic partnership with BRL Medicine Inc. (BRL Medicine). This collaboration will enhance the cell and gene therapy pipelines from BRL Medicine from clinical trials to...
2023-09-14 20:00
1838
Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease
PANGYO, South Korea, Sept. 14, 2023 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application of ADEL-Y01 for the treatment of Alzheimer's disease (AD). Oscotec and ADEL are jointly developing ...
2023-09-14 20:00
1448
Week's Top Stories
Most Reposted
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
[Picked up by 349 media titles]
2024-09-18 11:30
Singapore-based video streaming provider teams up with renowned celebrity platform to provide much-needed boost for brands
[Picked up by 326 media titles]
2024-09-13 17:12
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 315 media titles]
2024-09-16 11:50
NATIONAL ENERGY AWARDS 2024 SHOWCASES MALAYSIA'S COMMITMENT TO ENERGY MANAGEMENT, ENERGY EFFICIENCY AND RENEWABLE ENERGY SOLUTIONS
[Picked up by 289 media titles]
2024-09-13 15:00
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
[Picked up by 284 media titles]
2024-09-14 17:37
Most Read
NATIONAL ENERGY AWARDS 2024 SHOWCASES MALAYSIA'S COMMITMENT TO ENERGY MANAGEMENT, ENERGY EFFICIENCY AND RENEWABLE ENERGY SOLUTIONS
2024-09-13 15:00
14016
Singapore-based video streaming provider teams up with renowned celebrity platform to provide much-needed boost for brands
2024-09-13 17:12
13977
DITO Shares Experience and Future Strategy on 5G SA Core Network Construction
2024-09-13 11:00
9860
MELISHA LIN CROWNED MISS GRAND MALAYSIA 2024
2024-09-13 17:20
9732
